J&J said to face demand to lift Risperdal settlement offer by $800 million
By Bloomberg.com
Posted: March 12, 2012 - 1:45 pm ET
Tags:
Johnson & Johnson faces a U.S. government demand to raise its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing of the anti-psychotic Risperdal, according to three people familiar with the matter.
Switch to the new Modern Healthcare Daily News app
For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.